{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T22:53:35Z","timestamp":1784328815061,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1007\/s00520-006-0180-0","type":"journal-article","created":{"date-parts":[[2006,11,30]],"date-time":"2006-11-30T10:01:44Z","timestamp":1164880904000},"page":"63-71","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["The emerging role of cannabinoid neuromodulators in symptom management"],"prefix":"10.1007","volume":"15","author":[{"given":"Mellar","family":"Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Maida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Daeninck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Pergolizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,12,1]]},"reference":[{"key":"180_CR1","volume-title":"A physician\u2019s guide to pain and symptom management in cancer patients","author":"JL Abrahm","year":"2005","unstructured":"Abrahm JL (2005) A physician\u2019s guide to pain and symptom management in cancer patients, 2nd edn. Johns Hopkins University Press, Baltimore, MD","edition":"2"},{"key":"180_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s005200050154","volume":"6","author":"PL Andrews","year":"1998","unstructured":"Andrews PL, Naylor RJ, Joss RA (1998) Neuropharmacology of emesis and its relevance to anti-emetic therapy. Consensus and controversies. Support Care Cancer 6:197\u2013203","journal-title":"Support Care Cancer"},{"key":"180_CR3","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.lfs.2003.09.038","volume":"74","author":"DL Cichewicz","year":"2004","unstructured":"Cichewicz DL (2004) Synergistic interactions between cannabinoid and opioid analgesics. Life Sci 74:1317\u20131324","journal-title":"Life Sci"},{"key":"180_CR4","unstructured":"Cloning the receptor (Autumn 2005) O\u2019Shaughnessy\u2019s Journal of the California Cannabis Medical Research Group. Available at: http:\/\/www.ccrmg.org"},{"key":"180_CR5","volume-title":"Prescribing information","author":"Dronabinol (Marinol\u00ae)","year":"2005","unstructured":"Dronabinol (Marinol\u00ae) (2005) Prescribing information. Solvay Pharmaceuticals, Marietta, GA"},{"key":"180_CR6","first-page":"55","volume":"6","author":"S Green","year":"2005","unstructured":"Green S, Newman Z, Nordquist S (2005) Pharmacological evidence for cannabinoid receptors in glutamatergic synapses at the crayfish neuromuscular junction. Pioneering Neuroscience 6:55\u201361","journal-title":"Pioneering Neuroscience"},{"key":"180_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0006-8993(98)01321-3","volume":"822","author":"AG Hohmann","year":"1999","unstructured":"Hohmann AG, Briley EM, Herkenham M (1999) Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord. Brain Res 822:17\u201325","journal-title":"Brain Res"},{"key":"180_CR8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1155\/2001\/469629","volume":"6","author":"H Kalant","year":"2001","unstructured":"Kalant H (2001) Medicinal use of cannabis: history and current status. Pain Res Manag 6:80\u201391","journal-title":"Pain Res Manag"},{"key":"180_CR9","first-page":"1365","volume":"19","author":"J Khatcheressian","year":"2005","unstructured":"Khatcheressian J, Cassel JB, Lyckholm L, Coyne P, Hagenmueller A, Smith TJ (2005) Improving palliative and supportive care in cancer patients. Oncology (Williston Park) 19:1365\u20131376","journal-title":"Oncology (Williston Park)"},{"key":"180_CR10","doi-asserted-by":"crossref","unstructured":"Kris MG, Hesketh PJ, Somerfield MR et al (2006) American Society of Clinical Oncology Guideline for Antiemetics in Oncology: update 2006. Available at: http:\/\/www.asco.org","DOI":"10.1200\/JCO.2006.06.9591"},{"issue":"suppl A","key":"180_CR11","doi-asserted-by":"crossref","first-page":"7A","DOI":"10.1155\/2005\/169093","volume":"10","author":"ME Lynch","year":"2005","unstructured":"Lynch ME (2005) Preclinical science regarding cannabinoids as analgesics: an overview. Pain Res Manag 10(suppl A):7A\u201314A","journal-title":"Pain Res Manag"},{"key":"180_CR12","volume-title":"Prescribing information","author":"Nabilone (Cesamet\u2122)","year":"2006","unstructured":"Nabilone (Cesamet\u2122) (2006) Prescribing information. Valeant Pharmaceuticals International, San Diego, CA"},{"key":"180_CR13","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0278-5846(01)00245-7","volume":"26","author":"G Nahas","year":"2002","unstructured":"Nahas G, Harvey DJ, Sutin K et al (2002) A molecular basis of the therapeutic and psychoactive properties of cannabis (\u03949-tetrahydrocannabinol). Prog Neuropsychopharmacol Biol Psychiatry 26:721\u2013730","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"180_CR14","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1002\/cncr.11433","volume":"97","author":"S Poli-Bigelli","year":"2003","unstructured":"Poli-Bigelli S, Rodrigues-Pereira J, Carides AD et al (2003) Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America. Cancer 97:3090\u20133098","journal-title":"Cancer"},{"key":"180_CR15","first-page":"357","volume-title":"Pain management: a practical guide for clinicians","author":"EB Russo","year":"2002","unstructured":"Russo EB (2002) The role of cannabis and cannabinoids in pain management. In: Weiner RS (ed). Pain management: a practical guide for clinicians, 6th edn. CRC Press, Boca Raton, FL, pp 357\u2013375","edition":"6"},{"key":"180_CR16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ejphar.2005.11.036","volume":"530","author":"JD Roberts","year":"2006","unstructured":"Roberts JD, Gennings C, Shih M (2006) Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine. Eur J Pharmacol 530:54\u201358","journal-title":"Eur J Pharmacol"},{"key":"180_CR17","unstructured":"Sativex\u00ae oromucosal spray (2006). Available at: http:\/\/www.gwpharm.com\/sativex.asp"},{"key":"180_CR18","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1152\/jn.1999.82.1.472","volume":"82","author":"NM Strangman","year":"1999","unstructured":"Strangman NM, Walker JM (1999) Cannabinoid WIN 55,212-2 inhibits the activity-dependent facilitation of spinal nociceptive responses. J Neurophysiol 82:472\u2013477","journal-title":"J Neurophysiol"},{"key":"180_CR19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1136\/bmj.38149.566979.AE","volume":"329","author":"KB Svendsen","year":"2004","unstructured":"Svendsen KB, Jensen TS, Bach FW (2004) Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial. BMJ 329:253","journal-title":"BMJ"},{"key":"180_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/bmj.323.7303.16","volume":"323","author":"MR Tramer","year":"2001","unstructured":"Tramer MR, Carroll D, Campbell FA, Reynolds DJ, Moore RA, McQuay HJ (2001) Cannabinoids for control of chemotherapy-induced nausea and vomiting: quantitative systematic review. BMJ 323:16\u201321","journal-title":"BMJ"},{"key":"180_CR21","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0024-3205(99)00289-1","volume":"65","author":"JM Walker","year":"1999","unstructured":"Walker JM, Hohmann AG, Martin WJ, Strangman NM, Huang SM, Tsou K (1999) The neurobiology of cannabinoid analgesia. Life Sci 65:665\u2013673","journal-title":"Life Sci"},{"key":"180_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00520-003-0530-0","volume":"11","author":"D Walsh","year":"2003","unstructured":"Walsh D, Nelson KA, Mahmoud FA (2003) Established and potential therapeutic applications of cannabinoids in oncology. Support Care Cancer 11:137\u2013143","journal-title":"Support Care Cancer"},{"key":"180_CR23","first-page":"637","volume":"19","author":"W Wiser","year":"2005","unstructured":"Wiser W, Berger A (2005) Practical management of chemotherapy-induced nausea and vomiting. Oncology (Williston Park) 19:637\u2013645","journal-title":"Oncology (Williston Park)"},{"key":"180_CR24","unstructured":"World Health Organization (April 3, 2003) Global cancer rates could increase by 50% to 15 million by 2020. Available at: http:\/\/www.who.int\/mediacentre\/news\/releases\/2003\/pr27\/en\/index.html"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-006-0180-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-006-0180-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-006-0180-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-006-0180-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T02:29:11Z","timestamp":1652581751000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-006-0180-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["180"],"URL":"https:\/\/doi.org\/10.1007\/s00520-006-0180-0","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12,1]]},"assertion":[{"value":"27 September 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}